logo
ProjectArchived

DoD Tuberous Sclerosis Complex Idea Development Award

The status, timeline and source of this project. A free account opens every field.

Source: Grants.gov

The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis and manifestations of TSC to improve the lives of individuals with TSC. Within this context, the FY13 TSCRP encourages applications that address one or more of these vital program Focus Areas: • Genetic, epigenetic, and non-genetic modifiers of TSC. • Preclinical models and therapeutic strategies

Status
Closed
Sector
Hospital, Aerospace & Defense, Government, Hotel
Location
United States of America
Updated
22 Jul 2026
Source
Grants.gov

ConstructChat

Ask ConstructChat about DoD Tuberous Sclerosis Complex Idea Development Award

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “DoD Tuberous Sclerosis Complex Idea Development Award” is an infrastructure initiative in the Hospital sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Participants

Sponsoring Agency

Status

Original status

archived

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis and manifestations of TSC to improve the lives of individuals with TSC. Within this context, the FY13 TSCRP encourages applications that address one or more of these vital program Focus Areas: • Genetic, epigenetic, and non-genetic modifiers of TSC. • Preclinical models and therapeutic strategies (e.g., cytotoxic agents, combination therapies). • Biomarkers for early detection, prognosis, and prediction of treatment outcomes (such as serum markers, imaging, electrophysiology, prenatal testing, and pharmacogenetics). • Impact of TSC manifestations in adults (e.g., care management, age-specific pathogenesis, epidemiology, renal, reproductive issues, and lymphangioleiomyomatosis [LAM]). • Long-term benefits and effects of mTOR inhibitors or other agents. • Novel strategies for diagnosis, treatment, and prevention of TSC manifestations including those geared toward early identification and intervention. • Cellular and molecular mechanisms of TSC and LAM pathogenesis. • Causes and treatment of epilepsy in TSC. • Causes and treatment of TSC-associated neurocognitive disorders including cognitive impairment, and psychiatric, behavioral, and sleep disorders. The FY13 TSCRP Idea Development Award supports high-impact, innovative research that will drive the field of TSC research forward. Preclinical studies are encouraged, but clinical trials are not allowed. Applications must include preliminary or published data that is relevant to TSC and the proposed research project. The TSCRP encourages applications for the Idea Development Award from new investigators including but not limited to: • New investigators in TSC who have not received more than $300,000 in total direct costs for TSC research as a Principal Investigator (PI) of one or more federally funded, non-mentored peer reviewed awards. • Established independent investigators in an area other than TSC seeking to transition into a career in TSC research.

Budget

Location

Country

United States of America (USA)

Source

Source reliability

High

Source

Grants.gov

URL

More Details

Record type

Project

Sector

Hospital, Aerospace & Defense, Government, Hotel

Article published date

2023-06-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project